Arkolith/Insider Trading/PVLA/Form 4

Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$420K
Net Open-Market Flow
-$420K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)4K$97.94$367K0
Jan 21, 2026Option exercise(M)2K$9.08$20K4K
Jan 21, 2026Option exercise(M)2K$7.14$15K2K
Jan 21, 2026Sell(S)553$95.49$53K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 21, 2026Option exercise(M)2K—$019K
Jan 21, 2026Option exercise(M)2K—$019K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-006237) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML